Cargando...
Movement of Poly-ADP Ribose (PARP) Inhibition Into Frontline Treatment of Ovarian Cancer
The use of poly (ADP-ribose) polymerase (PARP) inhibitors in the front-line management of advanced ovarian cancer has recently emerged as an exciting strategy with the potential to improve outcomes for patients with advanced ovarian cancer. In this article, we review the results of four recently pub...
Guardado en:
| Publicado en: | Drugs |
|---|---|
| Autores principales: | , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
2020
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7541632/ https://ncbi.nlm.nih.gov/pubmed/32852746 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40265-020-01382-0 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|